NET PROFIT (x1000 DKK)
EMPLOYEES
Biobad Scand. AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-1
|
-22
|
-3 |
| EBITDA |
-1
|
-22
|
-3 |
| Total assets |
18
|
20
|
42 |
| Current assets |
18
|
20
|
42 |
| Current liabilities |
2
|
3
|
2 |
| Equity capital |
16
|
17
|
40 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
88.9%
|
85.0%
|
95.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-5.6%
|
-110.0%
|
-7.1% |
| Current ratio |
900%
|
666.7%
|
2100% |
| Return on equity (ROE) |
-6.2%
|
-129.4%
|
-7.5% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.